PTCT
$38.76
Ptc Therapeutics
$.47
1.23%
PTCT
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($1.79)
Revenue:  $108.86 Mil
Tuesday
Aug 3
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PTCT reports earnings?
Beat
Meet
Miss

Where is PTCT's stock price going from here?
Up
Flat
Down
Stock chart of PTCT
Analysts
Summary of analysts' recommendations for PTCT
Score
Grade
Pivots
Resistance
$40.64
$40.08
$39.18

$38.62

Support
$37.72
$37.16
$36.26
Tweet
Growth
Description
PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.
Peers
InterCeptVertex PharmaceuticalsBioMarin PharmaceuticalRegeneron PharmaceuticalsBristol-Myers SquibbPfizerUltragenyx PharmaceuticalZoetisEli LillyMerck & Co.